Incidence of nonmelanoma skin cancer in patients with vitiligo who applied ruxolitinib cream

Simple item page
dc.contributor.authorEzzedine, Khaled
dc.contributor.authorWolkerstorfer, Albert
dc.contributor.authorWei, Shaoceng
dc.contributor.authorKorba, Abdelhak Amara
dc.contributor.authorKornacki, Deanna
dc.contributor.authorRosmarin, David
dc.contributor.departmentDermatology, School of Medicine
dc.date.accessioned2025-04-21T08:15:09Z
dc.date.available2025-04-21T08:15:09Z
dc.date.issued2025
dc.eprint.versionFinal published version
dc.identifier.citationEzzedine K, Wolkerstorfer A, Wei S, Korba AA, Kornacki D, Rosmarin D. Incidence of nonmelanoma skin cancer in patients with vitiligo who applied ruxolitinib cream. J Eur Acad Dermatol Venereol. 2025;39(4):e378-e380. doi:10.1111/jdv.20379
dc.identifier.urihttps://hdl.handle.net/1805/47196
dc.language.isoen_US
dc.publisherWiley
dc.relation.isversionof10.1111/jdv.20379
dc.relation.journalJournal of the European Academy of Dermatology and Venereology
dc.rightsAttribution-NonCommercial 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourcePMC
dc.subjectVitiligo
dc.subjectSkin cancer
dc.subjectTopical Janus kinase (JAK) inhibitors
dc.subjectRuxolitinib cream
dc.titleIncidence of nonmelanoma skin cancer in patients with vitiligo who applied ruxolitinib cream
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Ezzedine2024Incidence-CCBYNC.pdf
Size:
185.11 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Dermatology Works